Stankovic Srdjan R. 4
4 · ACADIA PHARMACEUTICALS INC · Filed May 3, 2022
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2022-04-29+9,616→ 58,053 total - Exercise/Conversion
Restricted Stock Units
2022-04-29−9,616→ 9,616 total→ Common Stock (9,616 underlying) - Sale
Common Stock
2022-05-02$18.18/sh−2,865$52,091→ 55,188 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Acadia common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.385, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The restricted stock units vest in four equal annual installments beginning April 29, 2020.